An Obesity-Centric Approach with and Without Anti-Obesity Medications Compared to the Usual-Care Approach to Management of Patients with Obesity and Type 2 Diabetes in an Employer Setting: A Pragmatic Randomized Controlled Trial (EMPOWER-T2D)
Description
CONCLUSIONS: Including anti-obesity medication was associated with superior weight loss with noninferior HbA(1c) reductions, warranting further evaluation in larger study populations of obesity-focused approaches to type 2 diabetes management
